MediVet-America Offering Drug Free Adipose Stem Cell Procedure Kits To A Limited Number Of Distributorships
Animal Stem Cells from MediVet Keep American Dream Alive
MediVet-America is awarding a limited number of distributorships for its major scientific advancement in animal stem cell regenerative therapy for pets and other animals suffering from osteoarthritis, hip dysplasia, ligament and cartilage injuries, and other degenerative diseases.
MediVet-America's new, drug-free Adipose Stem Cell Procedure Kit and equipment allows veterinary practitioner to now perform animal stem cell treatments entirely in their own clinics more quickly, effectively and economically compared to first generation animal stem cell therapy. The new procedure has been launched in the United States and Canada, where a total of $68 billion is spent annually on pet care.
Stem cell therapy can rejuvenate the quality of life for dogs, cats and horses experiencing arthritis, lameness, pain and a restricted range of motion.
"As pet owners in the U.S. spend $12 billion a year on vet bills alone -- double the amount of 10 years ago -- our distributors deliver cutting-edge technology to the doorstep of vets nationwide," said MediVet-America managing director Jeremy Delk. "It is an excellent opportunity for entrepreneurs in an expanding field. You don't need to be a rocket scientist to be selected as a MediVet distributor -- you simply need the passion of an animal lover, and a will to succeed."
"With Americans caring for 170 million dogs and cats, this is a once in a lifetime opportunity to be part of the next generation of stem cell technology, a field that is exciting, rewarding and profitable," Delk said. "Thanks to a breakthrough treatment in the animal kingdom, the American dream is still alive in these tough times."
"This new technology marks a significant milestone," said MediVet-America spokesman Dr. Mike Hutchinson, D.V.M., a leading practitioner in stem cell therapy who has performed more than 100 Adipose Stem Cell treatments on dogs and cats. "My independent research verifying MediVet's superior results in stem cell count and activation has made me a staunch supporter. I believe adult stem cells and MediVet's new application signifies the biggest breakthrough in veterinary medicine I have seen since entering the field 24 years ago."
The Adipose Stem Cell Procedure kit costs a fraction of the old method, and can be performed by a trained technician in about three hours; the animal is under anesthesia for only a short time.
To learn more, visit www.MediVet-America.com.
MediVet-America is awarding a limited number of distributorships for its major scientific advancement in animal stem cell regenerative therapy for pets and other animals suffering from osteoarthritis, hip dysplasia, ligament and cartilage injuries, and other degenerative diseases.
MediVet-America's new, drug-free Adipose Stem Cell Procedure Kit and equipment allows veterinary practitioner to now perform animal stem cell treatments entirely in their own clinics more quickly, effectively and economically compared to first generation animal stem cell therapy. The new procedure has been launched in the United States and Canada, where a total of $68 billion is spent annually on pet care.
Stem cell therapy can rejuvenate the quality of life for dogs, cats and horses experiencing arthritis, lameness, pain and a restricted range of motion.
"As pet owners in the U.S. spend $12 billion a year on vet bills alone -- double the amount of 10 years ago -- our distributors deliver cutting-edge technology to the doorstep of vets nationwide," said MediVet-America managing director Jeremy Delk. "It is an excellent opportunity for entrepreneurs in an expanding field. You don't need to be a rocket scientist to be selected as a MediVet distributor -- you simply need the passion of an animal lover, and a will to succeed."
"With Americans caring for 170 million dogs and cats, this is a once in a lifetime opportunity to be part of the next generation of stem cell technology, a field that is exciting, rewarding and profitable," Delk said. "Thanks to a breakthrough treatment in the animal kingdom, the American dream is still alive in these tough times."
"This new technology marks a significant milestone," said MediVet-America spokesman Dr. Mike Hutchinson, D.V.M., a leading practitioner in stem cell therapy who has performed more than 100 Adipose Stem Cell treatments on dogs and cats. "My independent research verifying MediVet's superior results in stem cell count and activation has made me a staunch supporter. I believe adult stem cells and MediVet's new application signifies the biggest breakthrough in veterinary medicine I have seen since entering the field 24 years ago."
The Adipose Stem Cell Procedure kit costs a fraction of the old method, and can be performed by a trained technician in about three hours; the animal is under anesthesia for only a short time.
To learn more, visit www.MediVet-America.com.
Category Article MediVet-America Offering Drug Free Adipose Stem Cell Procedure Kits To A Limited Number Of Distributors
